Domantis First To Win UK Innovation In Drug Discovery & Development Award

Domantis is the first winner of the UK Innovation in Drug Discovery & Development Award, one of three new BioEntrepreneur Awards sponsored by London First and UK Trade & Investment.

The award recognises Domantis’ contribution to the UK’s dominant position in the development of innovative medicine.

Executive VP and CSO Dr. Ian Tomlinson said, "I am delighted to receive this award which highlights Domantis’ pioneering approach to developing novel therapeutics based on human Domain Antibodies.”

“Domantis is currently building a rich pipeline of novel dAb medicines to combat disorders such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis (RA) and cancer.”

The two other finalists were Powdermed and Spirogen.

Domantis Limited

Domantis Limited
Drug discovery platform



DownloadFull Press Release